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The aim of this study was to identify factors which might predict nocturnal desaturation (defined as a fall of >4% 
from awake baseline level for 25 min) in normoxic or mildly hypoxic patients with stable COPD [arterial 0, 
saturation (SaO,) 2 91%]. 
The study was prospective in nature, had full ethical approval and was performed in the Respiratory Department 
of a city teaching hospital. 
Thirty-three patients [mean (SD) age 67.2 (9) years] with stable COPD [mean (SD) FEV, 36.8 (11.0) % pred.] were 
recruited via the respiratory outpatient clinics and through the respiratory wards. 
The following parameters were measured: daytime arterial blood gases; spirometry; lung volumes (helium 
dilution); single breath CO transfer factor (ZYCO and KCO); maximum inspiratory (IMP) and expiratory mouth 
pressures; pulse oximetry (SpO,) across a 6-min walk test, and SpO, during sleep. 
Seventeen patients who experienced nocturnal desaturation had significantly lower mean PaO, and SaO,, and 
higher PaCO, values compared to non-desaturators. There was a positive correlation between mean nocturnal SpO, 
and daytime PaO,, SaO,, and minimum exercise SpOZ, and a negative correlation between mean nocturnal SpO, 
and PaCO,, and FRC. Regression analysis revealed that daytime SaO, was the only independent predictor of mean 
nocturnal saturation (accounting for 61% of the variability in the mean nocturnal SpO,). We observed nocturnal 
desaturation in all patients with a daytime SaO, 193% but in no patient with SaO, 295%. 
We conclude that daytime SaO, can be used to predict nocturnal desaturation in normoxic or mildly hypoxic 
patients with stable COPD. Nocturnal desaturation is likely in patients with COPD where daytime SaO, 5 93%, and 
unlikely where daytime SaO, 2 95%. 
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Introduction 
Episodes of significant oxygen desaturation and hypoxae- 
mia may occur during sleep in patients with chronic 
obstructive pulmonary diseasg (COPD) and these episodes 
can be adequately treated with long-term supplemental 
oxygen (1). It has been suggested that even transient 
elevations of pulmonary artery pressure consequent upon 
nocturnal oxygen desaturation may lead to the develop- 
ment of car pulmonale (2), although recent evidence casts 
doubt on this hypothesis (3). Certainly patients with COPD 
who experience nocturnal falls in oxygen saturation have 
poorer quality of sleep compared to healthy controls and 
their quality of life relates to the severity of the hypoxaemia 
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(4). In addition, mortality in COPD patients is greater at 
night when compared with age-matched controls, and noc- 
turnal death is particularly common in COPD patients who 
are hypoxaemic and hypercapnic (5). Furthermore, in 
hypoxaemic patients with COPD nocturnal death is more 
common in those breathing air than in those receiving 
supplementary oxygen (6). 
Since formal sleep studies are expensive and require 
specialized equipment many daytime parameters have been 
examined in an attempt to identify a subgroup in whom 
nocturnal desaturation is likely. In 1987 Fletcher et al. 
found that a group of patients with COPD who suffered 
nocturnal desaturation but had an awake PaO, above 
8 kPa had lower daytime PaO, and higher PaCO, com- 
pared to a group who did not suffer nocturnal desaturation 
(7). Bradley et al. also showed daytime hypercapnia to be a 
risk factor for the development of nocturnal desaturation in 
this group of patients (8), and both Connaughton et al. and 
Levi-Valensi et al. have demonstrated correlation between 
daytime and nocturnal saturation in similar patients (2,9). 
Vos et al. also measured lung function but only report 
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analysis of daytime PaO,, hypercapnic ventilatory response 
and sleepiness, noting usefulness of these in predicting 
nocturnal desaturation (1). They suggest that other par- 
ameters may be useful, citing measures of respiratory 
muscle function, and Heijdra and colleagues assessed this in 
their study in 1995 (10). This revealed correlation of 
nocturnal saturation with daytime saturation predomi- 
nantly, but also with forced expiratory volume in 1 s 
(FEV,) and inspiratory mouth pressure. Exercise saturation 
has also been examined (11) but no correlation was 
identified. 
Although the consequences in terms of prognosis and 
quality of life of nocturnal desaturation in normoxic or 
mildly hypoxic patients with COPD have yet to be estab- 
lished, there is at least theoretical evidence to suggest that it 
may be detrimental. These patients do not achieve the usual 
criteria for oxygen prescription and the aim of this study 
was to examine various parameters, including lung vol- 
umes, inspiratory mouth pressures and exercise saturation, 
in a group of COPD patients in whom daytime oxygen 
saturations were normal or only mildly reduced. From this 
we hoped to be able to identify daytime parameters, of use 
within the outpatient clinic setting, predicting a subgroup 
for which additional investigations might be appropriate. 
Methods 
We recruited 33 patients with moderate to severe COPD 
(FEV, ~70% pred.), according to criteria set by the 
American Thoracic Society (12). All patients were current 
or previous cigarette smokers and had a resting PaO, 
greater than 8 kPa, arterial oxygen saturation (SaO,) 
291% and no history of long-term oxygen therapy. Any 
patient with respiratory failure (PaO, ~8 kPa) or history 
suggestive of obstructive sleep apnoea was excluded. 
Static and dynamic lung volumes were measured using a 
Jaeger Masterscreen rolling seal spirometer (Erich Jaeger 
(U.K.) Ltd, Market Harborough, Leicestershire, U.K.), 
using helium dilution method for FRC. Reversibility 
studies were performed by administering 2.5 mg salbutamol 
via a Medic Aid CR 60 nebuliser (Medic-Aid Ltd, Pagham, 
Sussex, U.K.). Transfer factor (nC0 and KCO) was 
measured using the single breath technique with carbon 
monoxide (CO) as trace gas (Sensormedics [Rugby, 
Warwickshire, U.K.] System 2000 using mass flow sensor). 
An arterial blood sample was drawn from the radial 
artery and analysed immediately using an ABL 505 Blood 
Gas Analyser (Radiometer, Copenhagen, Denmark). 
Maximal inspiratory (IMP) and expiratory mouth pres- 
sure were measured with a Chest Ltd (Chest Scientific Ltd, 
Biggin Hill, Kent, U.K.) mouth pressure meter. A small 
leak (internal diameter 1.1 mm, length 40 mm) in the mouth 
piece prevents the buccal muscles from producing signifi- 
cant pressures and closing the glottis. The pressure within 
the mouth-piece was determined with a pressure transducer 
(model DP103-32: Validyne, Northridge, CA, U.S.A.). 
Each patient performed a 6-min walk test on the after- 
noon prior to the sleep study, with continuous oximetry 
(SpO,) throughout (Nellcor Symphony N-3000 Pulse 
Oximeter, Nellcor Incorporated, Pleasanton, CA, U.S.A.). 
Patients were asked to walk repeatedly along a 15-m length 
of corridor for 6 min, stopping if necessary, with the total 
distance ( f stops) recorded. The pre-exercise SpO, was 
taken as the stable, standing, SpO, for at least 30 s imme- 
diately prior to commencing exercise. Mean SpO, was the 
mean of all measurements during exercise, with the lowest 
SpO, reached during exercise recorded, together with the 
fall from the pre-exercise level. Exercise desaturation was 
defined as a fall of 24% from the baseline value. 
Nocturnal pulse oximetry was recorded with a Nellcor 
Symphony N-3000 pulse oximeter, the data being stored 
and digitized. Computer analysis gave mean nocturnal 
saturation with SD. Baseline SpO, awake was defined as the 
mean saturation during the first 15 min of the recording, 
with the patient supine but awake. Desaturation was 
defined as >4% fall in Sp02 from the baseline level for 
2 5 min. This was derived from Block et ul. (12) who 
described a desaturation as clinically significant when ~4% 
and from Fletcher et al. (13) who defined nocturnal desatu- 
ration as a fall below 90% for 25 min. This definition has 
also been used by Heijdra et al. (10,14). Mean nocturnal 
SpO, was that until final morning wakening, including 
intervening periods of wakefulness. Minimum SpO, was 
noted, this being the lowest instantaneous reliable record- 
ing, together with the fall from the baseline level. The pulse 
oximeter is calibrated to ignore values below 60”/0 as being 
unreliable. 
Data were analysed for mean and SD, with simple linear 
regression applied to single daytime parameters and noctur- 
nal SpO,. Stepwise multiple regression analysis was applied 
to evaluate the contribution of various parameters in the 
prediction of mean nocturnal SpO,. Differences in observed 
values between patients who desaturated and those who did 
not were compared using t-tests, both as absolute values 
and as percentage of predicted values, with all analysis 
being performed using a computerized statistical software 
package (Minitab Statistical Software, Minitab Inc., State 
College, PA, U.S.A.). 
Full approval was obtained from the West Ethics 
Committee. 
Results 
Thirty-three patients were recruited, 14 men and 19 women, 
of whom 17 experienced nocturnal desaturation as pre- 
viously defined. The total group was therefore subdivided 
into those who had nocturnal desaturation and those who 
did not. There was a significant difference between these 
two groups in terms of mean and minimum nocturnal SpO, 
(Table 1). Three patients were unable to perform mouth 
pressure measurements satisfactorily and one of these was 
also unable to perform the 6-min walk test. 
There was no significant difference in lung function 
between the two groups (Table l), but in the desaturating 
group daytime PaO, was significantly lower and PaCO, 
significantly higher than in those who did not desaturate. 
Similarly, the desaturators had a significantly lower 
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(n=16) (n= 17) P-value 
Pre-sleep SpO, (%) 93*8 (2.0) 95.0 (1.7) 92.7 (1.6) 0.0003 
Mean sleep SpO, (%) 93.1 (2.9) 94.9 (1.2) 91.4 (3.0) 0.0002 
Minimum sleep SpO, (%) 85.9 (8.3) 90.4 (2.2) 81.6 (9.8) 0.0019 
FEV, (% pred.) 36.8 (11.0) 37.1 (13.0) 36.6 (9.8) 0.91 
FVC (x pred.) 67.9 (16.8) 62.1 (17.0) 73.4 (15.1) 0.054 
FRC (% pred.) 129.6 (35.3) 123.6 (31.5) 135.3 (38.6) 0.34 
RV (% pred.) 165.5 (39.8) 163.5 (31.0) 167.3 (47.5) 0.79 
TLC0 (% pred.) 42.4 (21.9) 45.1 (22.9) 40.1 (21.4) 0.53 
KC0 (% pred.) 53.7 (27.5) 57.5 (26.2) 50.4 (29.0) 0.47 
PaO, (kPa) 9.3 (0.9) 9.9 (0.8) 8.8 (0.6) 0.0002 
PaCO, (kPa) 5.3 (0.5) 5.0 (0.5) 5.5 (0.3) 0.002 
SaO, (%) 93.9 (1.6) 95.1 (1.0) 92.8 (1.0) <0~0001 








(n= 17) P-value 
Pre-exercise 95.6 (2.1) 95.7 (1.4) 93.5 (2.1) 0.002 
Mean exercise 91.8 (3.7) 93.3 (2.7) 90.4 (4.1) 0.026 
Minimum exercise 89.8 (4.7) 91.8 (3.2) 88.1 (5.3) 0.023 
daytime SaO, when compared with the non-desaturating 
group. 
Analysis of the exercise data showed the desaturating 
patients to have significantly lower pre-exercise SpO, mean 
exercise SpO, and minimum SpO, (Table 2). 
There were significant positive correlations between 
mean nocturnal saturation and daytime saturation (r=0.78, 
P<O.OOl) (Fig. l), daytime PaO, (~0.56, P=O.OOl) and 
minimum exercise saturation (r=O.58, P<O.OOl). Statis- 
tically significant negative correlations were identified 
between mean nocturnal saturation and PaCO, (I= - 0.52, 
P=O.O02) and between mean nocturnal saturation and 
functional residual capacity (FRC) (r= - 0.36, P=O.O41). 
Mean nocturnal saturation did not correlate with other 
lung function measurements, in particular FEV, (Fig. 2). 
Regression analysis revealed that daytime SaO, was the 
only independent predictor of mean nocturnal desatura- 
tion, accounting for 61% of the variability in the mean 
nocturnal SpO,. 
Further analysis of the nocturnal desaturating group 
compared with the non-desaturating group revealed that no 
patient with a daytime SaO, 295% experienced nocturnal 
desaturation (a negative predictive value of lOO%, with a 
sensitivity of 100% and a specificity of 56%), and all 
patients with a daytime SaO, < 93% had nocturnal desatu- 
ration, a positive predictive value of 100% (sensitivity 65%, 
specificity 100%). In addition, 85% of patients with a 
minimum exercise oxygen saturation I 90% experienced 
nocturnal desaturation (positive predictive value of 85%, 
sensitivity 65% and specificity 87%) compared with 32% of 
those whose minimum exercise saturation was >90% (nega- 
tive predictive value of 68%) (Table 3). Lung function tests 
had a poor predictive value in determining nocturnal 
arterial desaturation (Table 4). 
Discussion 
We have shown that there are differences in daytime 
parameters between those patients who experience noctur- 
nal desaturation and those who do not, with the former 
group having a lower mean daytime saturation, PaO,, and 
minimum saturation on exercise, and higher daytime PCO,. 
Mean nocturnal saturation correlates positively with day- 
time saturation, PaO, and minimum exercise saturation, 
and negatively with daytime PCO, and FRC, although on 
regression analysis only SaO, is found to be an independent 
predictor of mean nocturnal saturation. Having shown this 
we examined the predictive power of daytime saturation 
with regard to nocturnal desaturation. By taking an arbi- 
trary level of daytime SpO, of 93% we have revealed that all 
patients below this level experienced nocturnal desatura- 
tion. Similarly all patients with a daytime saturation >95% 
did not experience nocturnal desaturation. Minimum 
exercise saturation appears less useful although 85% of 
those with a minimum SpO, on exercise ~90% suffered 
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FIG. 2. Correlation of FEV, % predicted and mean 
nocturnal oxygen saturation. x , Non-desaturators; 
0, desaturators; r= - 0.128; PxO.48. 
nocturnal desaturation. These values may have clear clini- 
cal application and we therefore suggest that daytime 
parameters can be employed to screen patients with COPD 
who are normoxic or only mildly hypoxic in order to 
predict those patients who are likely to suffer nocturnal 
desaturation. 
From our study, daytime arterial oxygen saturation 
proved to be the only independent predictor of mean 
nocturnal saturation in the study group, explaining 61% of 
the variability of mean nocturnal SpO,. The significance of 
daytime SaO, in predicting the nocturnal saturation has 
been demonstrated previously (8), with SaO, and PaCO, 
accounting for 68% of the variability of the nocturnal 
saturation in patients with COPD. A further study has also 
shown a high correlation between daytime and nocturnal 
SaO, in such patients (9) although saturation did not 
add to spirometry in terms of determining survival. 
Heijdra et al. also demonstrated FEV, to be a predictor of 
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nocturnal desaturation (lo), in contrast to our own and 
previous studies (7,15), possibly because of the wide range 
of FEV, values (0.61-3.21) in the patients included. Whilst 
FEV, is a predictor of mortality in COPD we did not find 
lung function to be a useful predictor of nocturnal desatu- 
ration in those patients who are normoxic or only mildly 
hypoxic at rest. Furthermore, and in contrast to Heijdra et 
a/. (10). mouth pressures did not correlate with nocturnal 
saturation, nor was there a difference in these measure- 
ments between the group who experienced nocturnal de- 
saturation and those who did not. Overall, the positive and 
negative predictive values based upon lung function suggest 
that FEV,, FRC and IMP are not useful in predicting 
nocturnal desaturation. In contrast to one previous study 
(11) we found a correlation between minimum exercise SpO, 
and mean nocturnal saturation, but this did not prove to be 
an independent predictor in a multiple regression analysis. 
In contrast to our own and the above published studies, 
one recent article disputes the predictive value of these 
daytime parameters with regard to nocturnal desaturation, 
noting no correlations with the exception of daytime 
PaCO, (3). One difficulty with all these studies is lack 
of agreement of what constitutes ‘clinically significant’ 
nocturnal desaturation in a group for whom the long-term 
consequences are not known and the benefit (or lack) of 
intervention is unproven. The definition employed in this 
study has been used previously (10,14) although a fall in 
saturation from baseline awake may not allow for physio- 
logical hypoventilation. However, it may be that this 
element is important in this group of patients if the result- 
ing desaturation is ‘clinically significant’. Fletcher et al. 
included a decrease from baseline asleep in their definition 
(16). as did Wynne and colleagues (17) but in the latter case 
no time-limit was included. This also applies to Vos et al. 
who again employed a decrease of >4% from baseline 
asleep (1) and Baldwin et al. who used a fall >5”/ (1 I), but 
again without time duration. From Fletcher et al. (18) in 
general a serious desaturation lasted longer than 5 min so 
a time period should probably be included within a 
definition. Levi-Valensi et crl. (2) and Gorecka et al. (19) 
employed a different definition, where patients were consid- 
ered desaturators if they spent 2 30% of sleep with an SpOz 
<90%. 
These differences in definition of ‘clinically significant’ 
desaturation will undoubtedly produce variation in results 
of clinical studies, but until agreement is reached each must 
be considered in the context of its use. For the purposes of 
this study, particularly as we wished to measure mouth 
pressures, it seemed reasonable to use the definition listed, 
matching as it does that used by Heijdra et al. in their 
research. 
COPD is a condition affecting a large population, with 
significant morbidity and mortality. Continuous supple- 
mental oxygen has been shown to improve longevity in 
COPD patients who are significantly hypoxaemic (PaO, 
~7.3 kPa) during the day (20,21). Recent research has 
shown a lack of survival benefit ,from oxygen therapy 
in patients with COPD but only moderate hypoxaemia 
(PaO, 748.7 kPa) (19). That study, however, did not look 
specifically at nocturnal desaturation and there is a 
Nocturnal oxygen saturation Predictive value 
Nocturnal Nocturnal 
desaturators non-desaturators Positive Negative 
Daytime arterial oxygen saturation 
295% 0 9 100% 
<95% 17 7 71% 
Daytime arterial oxygen saturation 
>93% 6 16 73% 
193% 11 0 100% 
Minimum exercise oxygen saturation 
>90% 6 13 68% 
190% 11 2 85% 
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TABLE 3. Predictive value of arterial oxygen saturation in determining nocturnal arterial desaturation 
TABLE 4. Predictive value of lung function in determining nocturnal arterial desaturation 
Nocturnal oxygen saturation Predictive value 
Nocturnal Nocturnal 
desaturators non-desaturators Positive Negative 
Functional residual capacity (% pred.) 
> 120% 12 8 60% 
I 120% 5 8 62% 
FEV, (% pred.) 
>35% 8 7 47% 
135% 9 9 50% 
Inspiratory mouth pressure (cm H,O) 
>50% 7 8 53% 
150% 9 6 60% 
group of patients who do not fulfil daytime criteria for 
supplementary oxygen yet experience nocturnal desatura- 
tion with its associated problems. This may not be apparent 
on evaluation of daytime blood gas values alone (2) but 
nevertheless these transient nocturnal episodes of desatura- 
tion may be accompanied by elevated pulmonary artery 
pressure (16) with the potential for associated morbidity 
(22,23). 
The ideal is to identify the subgroup for which there is 
potential benefit from supplementary oxygen without 
recourse to time-consuming and costly sleep studies in the 
whole population. It might be expected that those patients 
with more severe disease, and hence with lower daytime 
saturation, would have a lower mean nocturnal saturation. 
Similarly those with exercise desaturation are also more 
likely to be severely affected by their disease and hence have 
nocturnal desaturation. A causal relationship between noc- 
turnal desaturation and pulmonary hypertension is possible 
(2), although recent work disputes this (3). Supplemental 
oxygen has been shown to have a beneficial role in reducing 
pulmonary artery pressure in COPD patients with noctur- 
nal desaturation but only mild daytime hypoxia (13). To 
date mortality improvement has not been demonstrated, 
with a recent retrospective study of COPD patients pre- 
scribed oxygen whilst having PaO, 2 8 kPa showing sur- 
vival similar to more hypoxaemic patients (24). Again, 
however, this was a heterogeneous group with the study not 
assessing nocturnal desaturation. Certainly there appears to 
be a theoretical mechanism for mortality and/or morbidity 
benefit for patients who suffer nocturnal desaturation, but 
this remains to be clarified (25). Further research in this 
area is ongoing and the results from the intervention study 
by Chaouat and colleagues (3) must be awaited with 
interest. 
We have shown that daytime parameters, such as can be 
used in the outpatient clinic setting, can be utilized to 
identify patients in whom nocturnal desaturation is likely, 
in whom further assessment may be warranted, and also to 
exclude patients in whom nocturnal desaturation is 
unlikely. 
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Conclusion 
We conclude that daytime arterial oxygen saturation is an 
independent predictor of mean nocturnal saturation, 
although the correlation is not such that nocturnal SpO, 
can be precisely predicted for individual patients. However 
nocturnal desaturation is likely in patients with COPD 
where SaO, 193%. 
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